期刊文献+

肿瘤外科临床药师参与结直肠外科患者的药学监护实践 被引量:1

Clinical Pharmacists in Oncology Surgery Participate in the Practice of Pharmacological Care for Patients in Colorectal Surgery
原文传递
导出
摘要 目的探讨肿瘤外科临床药师药学监护重点。方法总结归纳肿瘤外科临床药师在结直肠病区中的临床药学实践,以1例典型的结直肠癌肝转移综合治疗患者多学科(MDT)诊疗模式为例,阐述肿瘤外科药师在MDT团队工作的切入点及围术期药学监护重点。结果结合肿瘤MDT的治疗模式,初步摸索出肿瘤外科临床药师的常规工作药学监护关键点。临床药师针对拟进行肿瘤外科治疗患者药物治疗相关问题提出意见和建议,优化术前抗肿瘤药物用药史与手术的间隔时间、围术期的营养支持治疗的制定、肿瘤患者深静脉血栓的预防、出院后患者用药教育等。结论作为MDT团队成员之一,肿瘤外科药师参与并实施药学监护后,有利于保障患者用药安全、有效,改善患者预后,发挥药学专业优势,体现药学服务的价值。 OBJECTIVE To discuss the key points of pharmacological care for clinical in oncology surgery.METHODS The clinical pharmacy practice of pharmacists in oncology surgery in the colorectal ward were summarized.A typical multidisciplinary team(MDT) diagnosis and treatment model of a typical patient with liver metastasis from colorectal cancer was selected.And the entry point and the focus of perioperative pharmaceutical care were explained at the work of the oncology surgery pharmacist in the MDT team.RESULTS Combined with the treatment mode of oncology MDT,the key points of routine work pharmacy care of clinical pharmacists in oncology surgery were initially explored.Clinical pharmacists put forward opinions and suggestions on drug treatment-related issues for patients who were planning to undergo surgical treatment of tumors,optimized the preoperative history of antitumor drug use and the interval between surgery,the formulation of perioperative nutritional support treatment,the prevention of deep vein thrombosis in oncology patients,post-discharge patient medication education,etc.CONCLUSION As a member of the MDT team,after the oncological surgeon pharmacist participates in and implements pharmaceutical care,it will ensure the safety and effectiveness of patients’ medication,improve patient prognosis,give full play to the professional advantages of pharmacy,and reflect the benefits of drug services value.
作者 魏雪 孔令亨 潘莹 张荣欣 李晓燕 黄红兵 刘韬 WEI Xue;KONG Lingheng;PAN Ying;ZHANG Rongxin;LI Xiaoyan;HUANG Hongbing;LIU Tao(Department of Pharmacy,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer medicine,Guangzhou,Guangdong 510060,China;Department of Colorectal Surgery,Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer medicine,Guangzhou,Guangdong 510060,China)
出处 《今日药学》 CAS 2022年第1期52-56,共5页 Pharmacy Today
基金 2018年肿瘤药事质控标准研究项目(Z19GDZS101)。
关键词 肿瘤外科临床药师 药学监护 临床药师 外科药学 围术期 oncology surgical pharmacists pharmaceutical care clinical pharmacist surgical medicine perioperative period
  • 相关文献

参考文献7

二级参考文献105

  • 1江志伟,李宁,黎介寿.快速康复外科的概念及临床意义[J].中国实用外科杂志,2007,27(2):131-133. 被引量:1357
  • 2黎介寿.对Fast-track Surgery(快通道外科)内涵的认识[J].中华医学杂志,2007,87(8):515-517. 被引量:366
  • 3Hannes P. Neeff,Oliver Drognitz,Andrea Klock,Gerald Illerhaus,Oliver G. Opitz,Ulrich T. Hopt,Frank Makowiec.Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases[J]. International Journal of Colorectal Disease . 2012 (5)
  • 4Stéphane Benoist MD, PhD,Bernard Nordlinger MD.The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases[J]. Annals of Surgical Oncology . 2009 (9)
  • 5Béatrice Aussilhou MD,Safi Dokmak MD,Sandrine Faivre MD,Valérie Paradis MD,Valérie Vilgrain MD,Jacques Belghiti MD.Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab[J]. Annals of Surgical Oncology . 2009 (6)
  • 6Viniyendra Pamecha MS, MRCS, FEBS,Georgios Glantzounis,Niel Davies,Giuseppe Fusai,Dinesh Sharma,Brian Davidson.Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases[J]. Annals of Surgical Oncology . 2009 (5)
  • 7Daria Zorzi MD,Yun Shin Chun MD,David C. Madoff MD,Eddie K. Abdalla MD,Jean-Nicolas Vauthey MD.Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases[J]. Annals of Surgical Oncology . 2008 (10)
  • 8Michael D’Angelica MD,Peter Kornprat MD,Mithat Gonen PhD,Ki-Young Chung MD,William R. Jarnagin MD, FACS,Ronald P. DeMatteo MD, FACS,Yuman Fong MD, FACS,Nancy Kemeny MD,Leslie H. Blumgart MD, FACS, FRCS,Leonard B Saltz MD.Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study[J]. Annals of Surgical Oncology . 2007 (2)
  • 9Diane Goéré M.D.,Olivier Farges M.D., Ph.D.,Julien Leporrier M.D.,Alain Sauvanet M.D.,Valérie Vilgrain M.D.,Jacques Belghiti M.D..Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction[J]. Journal of Gastrointestinal Surgery . 2006 (3)
  • 10Tanaka K,Adam R,Shimada H,et al.Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. British Journal of Surgery . 2003

共引文献426

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部